Yuhan stands to potentially receive up to $1.25 billion in potential development and commercial milestone payments, along with tiered double-digit royalties on future net sales.

Gilead Sciences has abandoned a liver disease collaboration with Yuhan. A new study suggests Leqembi's vial design could cost Medicare hundreds of millions of dollars in waste each year.

Gilead Sciences Inc. terminated a potential $785 million licensing deal with Yuhan Corp. inked in 2019 to develop metabolic dysfunction-associated steatohepatitis (MASH) therapies. BioWorld Asia Deals ...

Yuhan Li is Associate Director of Learning Design in the Center for Digital Innovation in Learning at Boston College. With nearly 8 years of experience supporting faculty teaching in higher education, ...

4 Women's 4 x 200m Freestyle Relay 7:47.96 3 Women's 4 x 200m Freestyle Relay, Heats 7:49.58 Q 2 Women's 4 x 200m Freestyle Relay, Heats, Heat 2 7:49.58 4 Women's 4 x 200m Freestyle Relay, Final 7 ...

Yuhan Zhang is a seasoned economist and adviser with over 15 years of research and professional experience in both the public and private sectors, specialising in China's economy, investment valuation ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Yuhan is a PhD student/doctoral researcher in the research group of Behavioural Research for Inclusivity, Sustainability and Technological Transformation (BRISTT) at Sheffield University Management ...

The 20th century was a period of unprecedented changes in British woodland history regarding their extent, configuration, management and function. Taking into account the woodland management in ...

Doctoral researcher, digital technology enthusiast, APP developer would be. I research affordances of mobile applications and migrants' everyday nationhood and work with charities regarding migrants’ ...